OpenEvidence, a three-year-old AI startup dubbed "ChatGPT for doctors," has doubled its valuation to $12 billion after raising $250 million, driven by over $100 million in annual revenue from healthcare subscriptions. It offers evidence-based medical insights, amid rapid growth and regulatory challenges in AI healthcare.
OpenEvidence AI Startup Hits $12B Valuation with $250M Raise
